U.S. Markets closed

BioTelemetry, Inc. (BEAT)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.40-0.60 (-1.71%)
At close: 4:00PM EDT
People also watch
MASIAAOISUPNLMATATRC
Full screen
Previous Close35.00
Open35.25
Bid27.05 x 100
Ask38.00 x 200
Day's Range34.35 - 35.25
52 Week Range15.25 - 35.60
Volume319,701
Avg. Volume523,049
Market Cap985.74M
Beta1.14
PE Ratio (TTM)21.49
EPS (TTM)1.6
Earnings DateJul 31, 2017 - Aug 4, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est43.25
Trade prices are not sourced from all markets
  • BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
    Zacks5 days ago

    BioTelemetry (BEAT) Acquires LifeWatch for $280 Million

    BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.

  • BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher
    Zacks5 days ago

    BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher

    BioTelemetry (BEAT) was a big mover last session, as the company saw its rise nearly 7% on Friday amid huge volumes.

  • American City Business Journals7 days ago

    BioTelemetry completes $280M acquisition

    BioTelemetry Inc. completed its previously announced acquisition of LifeWatch AG in a cash and stock deal valued at about $280 million. Both medical technology companies make products used to remotely monitor cardiac care patients. “We are gratified that LifeWatch AG shareholders embraced the immense strategic value and potential of this acquisition and moved quickly to support the BioTelemetry tender,” said Joseph H. Capper, president and CEO of Malvern-based BioTelemetry Inc., in a prepared statement.